Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-01-24

Clinical Trial Update: A Single-center Pilot Study Evaluating the Immediate Effects of Low-dose Acetazolamide on Respiratory Control in Subjects With Treatment Emergent Sleep Disordered Breathing [NA]

View source ↗

Summary

This clinical trial update notes that a single-center pilot study evaluating the immediate effects of low-dose acetazolamide on respiratory control in treatment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: NYU Langone Health | Conditions: Sleep Apnea | NA | Status: WITHDRAWN